Dir
George M. Jenkins is a seasoned finance and investment executive serving as Chairman and Director of Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company developing therapies for rare genetic skin diseases.[[1]](https://www.marketscreener.com/insider/GEORGE-JENKINS-A076AM/)[[2]](https://www.gurufocus.com/insider/262648/george-m-jenkins)[[5]](https://palvellatx.com/about/) He joined as Independent Chairman in 2024, following the company's merger and name change in December 2024, and recently purchased 4,000 shares worth $500,000 on February 27, 2026, owning approximately 196,687 shares directly and indirectly.[[2]](https://www.gurufocus.com/insider/262648/george-m-jenkins)[[3]](https://www.investing.com/news/insider-trading-news/palvella-therapeutics-pvla-director-buys-500k-in-stock-93CH-4534699) Jenkins also holds positions as Chairman of Eagles Mere Historic Village, Inc., President and Treasurer of Merritt Field LLC (an investment firm), Director at Conventus Orthopaedics, Inc., and Trustee at Lafayette College.[[1]](https://www.marketscreener.com/insider/GEORGE-JENKINS-A076AM/)
Jenkins built his career in private equity and venture capital, notably as Chief Operating Officer and General Partner at Apax Partners, Inc. from 1987 to 2005, and previously as Vice President at Midlantic Banks, Inc.[[1]](https://www.marketscreener.com/insider/GEORGE-JENKINS-A076AM/) His extensive board experience includes directorships at Tessera Technologies LLC, SkinMedica, Inc., Flower Orthopedics Corp., Spyder Active Sports, Inc., Sunglass Hut, Inc., and Power Survey Corp., spanning finance, electronic technology, consumer services, and healthcare sectors.[[1]](https://www.marketscreener.com/insider/GEORGE-JENKINS-A076AM/) At 73 years old with a net worth estimated at $5 million as of 2025, Jenkins brings deep expertise in investment management to his roles.[[1]](https://www.marketscreener.com/insider/GEORGE-JENKINS-A076AM/)
View full insider profile →
